Image For Activity Cover
The Brain-Heart Team Approach: Secondary Prevention After a Presumed PFO-Mediated Stroke
Join expert faculty at a SCAI-sponsored dinner satellite symposium at the International Stroke Conference in Dallas, February 8. Faculty will present a case-based discussion on the brain-heart team approach to possible treatment options for patients with cryptogenic stroke and PFO. ISC23 attendees and non-attendees are welcome to attend.

Registration is complimentary.

This event is not part of the official International Stroke Conference 2023 as planned by the International Stroke Conference Program Committee.

Megan Coylewright, MD, FSCAI
Director, Structural Heart Program
Erlanger Heart and Lung Institute
Symposium Chair, Interventional Cardiology
Steven Messé, MD
Professor of Neurology
Hospital of the University of Pennsylvania
Symposium Chair, Neurology
Megan Stevens, MD
Vascular Neurologist Erlanger Hospital

University of Tennessee Chattanooga
Affiliated Assistant Professor Department of Neurology
Molly Szerlip, MD, FSCAI
Medical Director of the Percutaneous Valve Program
Baylor Scott & White
David E. Thaler, MD, PhD, FAHA
Chairman, Department of Neurology
Professor of Neurology
Director emeritus, The Comprehensive Stroke Center
Tufts University School of Medicine
John J. Volpi, MD
Associate Professor of Clinical Neurology
The Elkins Family Distinguished Centennial Clinical Academic Scholar in Neurology
Houston Methodist
  • Welcome & Introductions, Drs. Coylewright and Messé
  • Overview: Epidemiology and Burden of PFO-Associated Stroke, Dr. Volpi
  • State of the Evidence for PFO Closure, Dr. Thaler
  • Review of Current Practice Patterns, Dr. Messé
  • Structuralist’s View of the PFO, Dr. Szerlip
  • Building a Brain-Heart Team, Optimizing Patient Outcomes. A Tale of 3 Patients to Illustrate Our Team Goals, Drs. Coylewright and Stevens
  • Discussion
Learning Objectives

At the conclusion of this activity participants will be able to demonstrate the ability to:

  • Describe the epidemiology and burden of cryptogenic ischemic stroke
  • List competencies and resources necessary to constitute a Brain-Heart team
  • Perform the complete evaluation of ischemic stroke patients to determine stroke mechanism
  • Describe key clinical trial data regarding the safety and efficacy of FDA-approved devices for PFO closure to prevent secondary stroke
  • Suspect PFO in patients with cryptogenic stroke and ensure appropriate team-based evaluation
  • Deploy shared decision-making principles with cryptogenic stroke patients with PFO to determine the patients preferred secondary stroke prevention strategies
Acknowledgement of Commercial Support
This activity is supported through unrestricted educational grants from Abbott and W.L. Gore & Associates. No in-kind commercial support was received.
Accredited Continuing Education Information

Accreditation Statement
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the 
Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

​Credit Designation
SCAI designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.5 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.

Successful Completion
Attend the live activity and complete the evaluation to obtain credit.

© 2022-2024 Society for Cardiovascular Angiography and Interventions (SCAI). All rights reserved.
Availability: Retired
Cost: FREE
Credit Offered:
No Credit Offered
Powered By